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ABSTRACT Annually, an estimated 2 million osteoporotic fractures occur in the United
States alone. Osteoporosis imparts a great burden on the health care system. The
identiﬁcation of novel regulators of bone health is critical for developing more effec-
tive therapeutics. A previous study on the colonization of germ-free (GF) mice with a
microbial community has demonstrated that bacterial colonization dramatically in-
creases bone loss. We therefore investigated the impact of multiple microbial com-
munities in different mice to understand how generalizable the impact of bacterial
colonization is on bone health. To investigate the impact of different microbial com-
munities on bone health in outbred and inbred mouse strains, gavage was per-
formed on GF Swiss Webster and GF C57BL/6 mice to introduce distinct microbiotas
that originated from either humans or mice. GF mice displayed a high degree of col-
onization, as indicated by more than 90% of the operational taxonomic units pres-
ent in the starting inoculum being successfully colonized in the mice when they
were examined at the end of the experiment. In spite of the successful colonization
of GF mice with gut microbiota of either mouse or human origin, bone mass did not
change signiﬁcantly in any of the groups tested. Furthermore, static and dynamic
bone parameters and osteoclast precursor and T cell populations, as well as the ex-
pression of several inﬂammatory markers, were mostly unchanged following micro-
bial colonization of GF mice.
IMPORTANCE The microbiota has been shown to be an important regulator of
health and development. With regard to its effect on bone health, a previous study
has suggested that gut microbes negatively impact bone density. However, we show
here that this is not generalizable to all microbial communities and mouse strain
backgrounds. Our results demonstrate that colonization of mice, both outbred and
inbred strains, did not have a major impact on bone health. The identiﬁcation of mi-
crobial communities that do not negatively impact bone health may provide a foun-
dation for future investigations that seek to identify microbes that are either beneﬁ-
cial or detrimental to bone metabolism.
KEYWORDS bone, microbiome, microbiota, osteoporosis
The intestinal microbiota is the collection of microbes, including bacteria, archaea,viruses, helminths, and fungi, that inhabit our gut. At birth, humans become
exposed to microorganisms that establish colonization at various body sites, including
the skin, mouth, gastrointestinal (GI) tract, and vaginal epithelium. These body sites
serve as the interface that fosters interactions between the microbes and their respec-
tive host. Furthermore, several studies have demonstrated the importance of the
microbiota in the development and maintenance of health. For example, germ-free (GF)
mice have decreased gut lymphoid tissue development, as well as altered microvillus
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architecture (1, 2). Moreover, GF mice have decreased expression levels of pattern
recognition receptors that detect microbes (e.g., Toll and NOD-like), as well as of
antimicrobial peptides (e.g., Reg3), which strongly highlights how the microbiota
impacts the functional role of the immune system (2, 3). In animal disease models, the
ability to mount an immune response is also hindered in GF animals and restored upon
conventionalization (i.e., restoration of microbiota from an animal raised under stan-
dard laboratory conditions) (4, 5).
Recently, more emphasis has been placed on the role of the microbiota in
skeletal health (6, 7). The rationale for this is based on the known impact of the
microbiota on multiple facets of the immune system, the importance of the immune
system in bone remodeling, and the gut that serves as a messenger between the
two (8–10). Bone remodeling, which is composed of the coupled processes of bone
formation and bone resorption, undergoes various phases throughout life. In early
human life, bone formation outweighs bone resorption and contributes to in-
creased bone deposition until a plateau is reached in early adulthood (11). Then, a
shift in favor of bone resorption takes place, with bone loss gradually increasing
over time. Different pathologies can accelerate bone loss by impacting the pro-
cesses of bone formation by osteoblasts and bone resorption by osteoclasts (OCL).
Under many different pathological bone conditions, the primary driver of bone loss
is increased osteoclastic bone resorption that is oftentimes mediated by immune
signaling (12, 13).
Osteoclasts originate from monocytic precursors in the bone marrow, and many
studies have demonstrated their interaction with and regulation by immune cells like
B and T cells (14–17). In addition to impacting the local immune response in the gut,
the microbiota has also been shown to regulate the immune response and hemato-
poiesis at distant sites, including the bone marrow (18). Thus, we and others hypoth-
esized that the gut microbiota is an important factor that impacts bone health through
its regulation of the immune system (7, 19, 20).
A previous study has shown that bone density is negatively regulated by the
presence of the microbiota. By comparing female GF mice and conventionalized
(CONV-D) mice in the C57BL/6 genetic background, it was shown that the gut
microbiota markedly decreased bone mass (19). In addition, CONV-D mice also
displayed an expansion in osteoclast precursor cells, CD4 T cells, and serum
serotonin levels. These results were intriguing given that increased immune cell
populations and serotonin levels are important driving factors in the development
of osteoporosis (8, 21, 22). In direct contrast, Schwarzer et al. demonstrated that
various bone parameters associated with bone health were decreased in GF BALB/c
animals compared to the results for wild-type (WT) mice (23). More recently,
estrogen deﬁciency-induced bone loss was shown to require the presence of the
microbiota in order for bone loss to occur (20).
Although these studies indicated that bone density is regulated by the presence of
the microbiota, the conﬂicting results did not resolve the roles that speciﬁc microbial
community member(s) play in determining bone health. Therefore, in this study, we set
out to identify speciﬁc bacterial species that impact bone health by colonizing GF Swiss
Webster (SW) mice with microbial communities from diverse fecal donors and charac-
terizing the impact of these communities on bone health. Contrary to previous results,
our study demonstrates that the colonization of GF mice with several different micro-
bial communities does not result in increased or decreased bone mass. Additionally,
these studies were performed in both outbred (SW) and inbred (C57BL/6) mouse
genetic backgrounds. Through comparative 16S rRNA gene analysis, we identiﬁed
separate and distinct clustering of microbial communities based upon mouse genetic
background. Thus, our results underscore the importance of testing different microbial
communities before generalizing ﬁndings to encompass all microbiota.
(Part of this work was published in Darin Quach’s Ph.D. thesis at Michigan State
University [24].)
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RESULTS
Presence of a human gut microbiota does not impact bone mass in Swiss
Webster mice. To identify speciﬁc microbes that affect bone health, we investigated
the impact of different human microbial communities in GF mice. Four-week-old
female GF SW mice were humanized by intragastric gavage with fecal microbial
communities from healthy human volunteers. In total, 3 different human microbial
communities were used for colonization, as well as cecal contents from WT SW mice
(Table 1). After 12 weeks of colonization, bone mass in the distal femur was measured,
and we found that there was no signiﬁcant difference between the bone volume
fraction (BVF) values of GF mice and mice colonized with our collection of human
microbiotas or the cecal content of the mouse (Fig. 1) (P  0.61).
Femur lengths and body weights were not signiﬁcantly different among the treat-
ment groups (Table 2). Other femur bone parameters, such as bone mineral density
(BMD), trabecular thickness (Tb. Th.), trabecular number (Tb. N.), and trabecular spacing
(Tb. Sp.), were similar between GF and CONV-D mice (Table 2). Cortical (Ct.) bone
parameters, such as volume, thickness, and moment of inertia (MOI), were not signif-
icantly different between GF mice and mice colonized with a microbiota (Table S1 in
the supplemental material). These data show that colonization of GF mice with human
or mouse microbial communities had no impact on bone health in the SW outbred
genetic background.
Presence of a normal mouse gut microbiota does not impact bone mass in
female Swiss Webster or C57BL/6 mice. Previous work demonstrating a negative
impact on bone mass following the reconstitution of microbiota in GF mice was
performed in female C57BL/6 mice (19). To test whether the lack of impact on bone
health following microbiota colonization in this study was due to the mouse genetic
background, we conventionalized 4-week-old female SW and C57BL/6 GF mice with
microbial communities prepared from cecal contents of genetic background-, age-, and
sex-matched mice raised in the Baylor College of Medicine mouse facility. Following
4 weeks of colonization, we compared the BVFs of the distal femurs between GF and
CONV-D mice and observed that there was no signiﬁcant difference between the two
groups in either the SW (Fig. 2a) (P  0.15) or the C57BL/6 (Fig. 2b) (P  0.14) genetic
TABLE 1 Description of microbiotas used in mouse studies
Microbiota source Description
CONV-D Cecal contents of mice conventionally raised with mouse microbiota
Sample A Fecal sample collected from healthy human vegetarian
Sample B Sample collected at year 1 from individual who provided sample C
Sample C Sample collected at year 0 from healthy human omnivore
FIG 1 Trabecular bone volume fraction (BVF) values (shown as bone volume per total volume analyzed
[BV/TV]) for GF Swiss Webster (SW) mice after colonization with different human microbiotas. Four-week-
old female germ-free (GF) Swiss Webster mice were colonized with different human microbiotas (samples
A to C) for 8 weeks. The GF and conventionalized (CONV-D) groups served as controls. The results for
individual mice and the mean values  SEM (n  3 to 7) are shown.
Gut Colonization Does Not Cause Bone Loss in Germ-Free Mice
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background. Conventionally reared (CONV-R) mice, used as a control, displayed a mean
BVF that was not statistically different from that of the GF or CONV-D group (Fig. 2a).
Measurements for BMD, Tb. Th., Tb. N., and Tb. Sp. were similar between GF and
CONV-D mice at 8 weeks of age in the SW background (Table 3). Statistically signiﬁcant
differences in Tb. N. and Tb. Sp. were observed in C57BL/6 mice despite not observing
a signiﬁcant difference in BVF or BMD. In addition, the lack of a signiﬁcant difference in
the MOI suggests that there is no difference in the bone structural strength between
GF and CONV-D mice (Table S2). A comparison of the cortical volume and thickness
from the midshaft of the femur also demonstrated no difference between the two
groups in the C57BL/6 background (Table 4).
Presence of a normal mouse gut microbiota does not impact bone mass in
male Swiss Webster mice. Sex differences have been shown to impact various facets
of bone metabolism (25–27). Previous studies on the role of the gut microbiota in bone
density examined female mice (19). To begin understanding whether sex plays a role
in determining the impact of the microbiota on bone health, we conventionalized
4-week-old male GF Swiss Webster mice as well. Similar to the results for their female
counterparts, the presence of a microbiota did not impact the BVF (Fig. 2c) (P 0.9253).
These results demonstrate that neither sex nor genetic background impacts bone mass
in response to microbial colonization of GF mice.
Histomorphometric analysis of the distal femur. Histomorphometry was per-
formed on the distal femur to determine static and dynamic bone parameters. We
observed no signiﬁcant differences between the number of osteoclasts (OCL) per
trabecular bone surface between GF and CONV-D Swiss Webster mice. Consistent with
the bone results thus far, no signiﬁcant differences were observed when we compared
the results in different groups for mineralizing surface per trabecular bone surface
(MS/BS), bone formation rate (BFR), and mineral apposition rate (MAR) (Table 5; Fig. S1).
Conventionalization does not impact T cell populations or OCL precursor cells
and outgrowth in GF and CONV-D mice. An imbalance in bone remodeling that
favors osteoclastic bone resorption often leads to pathological bone loss; T-cell-driven
osteoclastogenesis is one of the reasons for this osteoclastic bone resorption (22, 28).
Previously, it was shown that the gut microbiota can decrease bone mass, which
correlated with increases in CD4 and CD8 T cell populations, as well as osteoclast
precursor cells (19). Therefore, we investigated whether the gut microbiota impacts
bone marrow T-cell populations and/or the amount of osteoclast precursors or oste-
oclastogenesis in SW mice in the presence or absence of a microbiota.
Flow cytometric analyses indicated that conventionalization of GF mice in the SW
genetic background did not signiﬁcantly impact the bone marrow T cell populations
(Fig. 3). Osteoclast differentiation was measured by quantitating the amount of giant
TABLE 2 Trabecular and cortical bone parameters for humanized Swiss Webster micea
Bone type, parameter
Mean value  SEM for samples from mice receiving indicated microbiota (no. of mice)
P valueGF (7) A (6) B (7) C (3) CONV-D (4)
Trabecular
BV/TV (%) 30.84  2.40 32.80  1.94 30.93  3.58 31.45  1.51 29.50  4.50 0.88
BMD (mg/cm3) 225.82  30.04 246.25  25.52 228.57  53.03 234.66  20.42 220.01  41.30 0.83
Tb. Th. (m) 5.74  0.71 6.44  0.25 5.87  1.20 6.11  0.75 5.79  0.56 0.64
Tb. N. (mm1) 5.32  0.72 5.03  0.44 5.18  1.01 5.12  0.56 5.03  1.10 0.98
Tb. sp. (m) 133.49  24.01 135.50  19.41 139.58  35.80 135.90  15.14 148.18  45.04 0.96
Cortical
Ct. volume (mm3) 0.98  0.01 0.98  0.01 0.98  0.01 0.97  0.01 0.97  0.01 0.08
Ct. thickness (m) 285.57  17.64 303.20  20.46 301.67  6.80 276.00  12.77 277.50  16.28 0.19
BMD (mg/cm3) 1,039.43  8.02 1,015.99  1.43 1,041.60  12.61 1,041.50  4.46 1,042.04  18.93 0.97
MOI (mm4) 0.11  0.03 0.09  0.01 0.10  0.01 0.08  0.04 0.09  0.01 0.30
Body weight (g) 35.04  2.40 32.01  1.17 33.45  0.96 32.75  1.15 31.74  1.09 0.78
Femur length (mm) 17.22  0.24 17.35  0.26 17.21  0.13 17.09  0.14 17.10  0.21 0.82
aThis table summarizes data from the experiment described in the legend to Fig. 1.
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multinucleated cells that stained positive for tartrate-resistant alkaline phosphatase
(TRAP) following stimulation with receptor activator of NF-kappa B ligand (RANKL) and
macrophage colony-stimulating factor (M-CSF) for 4 days. Consistent with there being
no changes in the T cell and OCL precursor populations, no signiﬁcant difference in OCL
outgrowth was detected in conventionalized mice compared to that in their GF
counterparts in both SW (Fig. 4a and b) and C57BL/6 mice (Fig. S2).
Analysis of inﬂammatory markers. Increased levels of various inﬂammatory cyto-
kines, most notably tumor necrosis factor alpha (TNF-), have been shown to promote
osteoclastogenesis and bone loss in human and animal studies (29–31). To investigate
whether the production of certain cytokines was regulated by the presence of a gut
microbiota, we compared the expression levels between GF and conventionalized mice
by performing quantitative real-time PCR (qRT-PCR) on the TNF-, interleukin-1
(IL-1), IL-6, serotonin reuptake transporter (SERT), gamma interferon (IFN-), IL-17A,
and IL-10 genes from colonic mRNA. With the exception of IL-17A mRNA expression
being increased and IL-10 being decreased, no genes that were examined were
FIG 2 Conventionalization of female GF SW and C57BL/6 mice does not impact bone density. Female
GF Swiss Webster (a) and C57BL/6 (b) mice and male GF Swiss Webster (c) mice were colonized with
conventional mouse microbiota for 4 weeks (conventionalized [CONV-D]). The GF group served as the
control. No differences in BVF were observed when conventionalized mice were compared to their GF
counterparts. CONV-R, conventionally reared. The results for individual mice and mean values  SEM
(n  3 to 10) are shown.
Gut Colonization Does Not Cause Bone Loss in Germ-Free Mice
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differentially regulated by the reconstituted gut microbiota in GF mice (Fig. 5a). In
accordance with these results, TNF- levels in the serum were not affected by conven-
tionalization (Fig. 5b).
Fecal microbial community analysis. For the mouse colonization studies, we
analyzed the microbial communities present in the fecal samples of mice at the
conclusion of the experiments by analysis of the V4 hypervariable region of the 16S
rRNA gene. Alpha and beta diversity measures reﬂected highly efﬁcient microbiota
transfer, since most of the species identiﬁed in the inocula were present in the recipient
CONV-D SW and C57BL/6 mice. Conventionalization of female C57BL/6 and SW mice
identiﬁed the presence of 178 (out of 182) and 296 (out of 315), respectively, of the
operational taxonomic units (OTUs) present in the original inocula (Fig. 6; Tables S3 and
S4). Interestingly, we found that transfers resulted in mouse strain-speciﬁc convention-
alization. Speciﬁcally, conventionalized mice of the C57BL/6 and SW genetic back-
grounds shared 154 OTUs, but an additional 31 OTUs were unique to C57BL/6 mice and
168 OTUs were unique to SW mice (Tables S3 and S4).
DISCUSSION
In this study, we focused on the impact of the microbiota on bone health, with the
goal of identifying microbes with therapeutic potential. Previous work demonstrated
TABLE 3 Trabecular and cortical bone parameters for conventionalized SW micea
Bone type, parameter
Mean value  SEM for samples from
mice receiving indicated treatment
(no. of mice)
P valueGF (6) CONV-D (8)
Trabecular
BV/TV (%) 32.16  4.78 28.57  3.71 0.14
BMD (mg/cm3) 269.73  32.74 253.17  28.75 0.33
Tb. Th. (m) 56.31  5.79 53.85  5.21 0.42
Tb. N. (mm1) 5.71  0.21 5.31  0.16 0.15
Tb. sp. (m) 149.85  5.77 160.55  6.51 0.26
Cortical
Ct. volume (mm3) 0.94  0.01 0.95  0.01 0.48
Ct. thickness (m) 244.38  2.63 242.15  2.18 0.32
BMD (mg/cm3) 1,074.78  9.83 1,083.66  12.49 0.92
MOI (mm4) 0.08  0.02 0.09  0.02 0.84
Body weight (g) 32.82  2.79 31.98  2.60 0.57
Femur length (mm) 16.79  0.27 16.47  0.56 0.22
aThis table summarizes data from the experiment described in the legend to Fig. 2a.
TABLE 4 Trabecular and cortical bone parameters for conventionalized C57BL/6 micea
Bone type, parameter
Mean value  SEM for samples from
mice receiving indicated treatment
(no. of mice)
P valueGF (10) CONV-D (8)
Trabecular
BV/TV (%) 9.33  0.54 8.46  0.49 0.26
BMD (mg/cm3) 109.91  10.79 98.48  12.09 0.07
Tb. Th. (m) 33.45  1.09 35.01  2.25 0.07
Tb. N. (mm1) 2.83  0.40 2.41  0.28 0.02
Tb. sp. (m) 203.91  14.08 229.94  11.88 0.001
Cortical
Ct. volume (mm3) 0.55  0.03 0.56  0.01 0.38
Ct. thickness (m) 162.38  2.63 166.88  2.18 0.21
BMD (mg/cm3) 963.58  23.71 954.22  23.05 0.41
MOI (mm4) 0.030  0.002 0.028  0.004 0.30
Body weight (g) 18.68  0.71 17.83  1.43 0.12
Femur length (mm) 12.41  0.62 12.29  0.46 0.67
aThis table summarizes data from the experiment described in the legend to Fig. 2b.
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that conventionalizing female GF C57BL/6 mice with a normal mouse gut microbiota
decreased bone mass and negatively impacted bone health (19). Additionally, it was
demonstrated by Sjögren et al. (19) that several immune and bone parameters were
impacted in the presence of the microbiota and that these correlated with bone loss.
Overall, our ﬁndings demonstrate that the introduction of deﬁned microbiotas to GF
animals does not signiﬁcantly alter bone mass in males or females in two different
mouse genetic backgrounds. Despite the fact that the expression levels of IL-10 and
IL-17 in the colon (Fig. 5b) were impacted in a way that has been shown to favor the
development of osteoporosis (32–34), serum levels of TNF- and T cell populations in
the bone marrow compartment were not impacted by the presence of a microbiota
(Fig. 3). This highlights the need to consider the mouse background and microbial
communities to be tested when considering the impact of bacterial colonization on
bone health.
While there was a downward trend in bone mass in CONV-D mice (Fig. 2), the
changes were minor and not signiﬁcant. Only a less than 5% decrease in BVF was
observed, which is in stark contrast to the 30 to 40% decrease that was previously
demonstrated (19). Similarly, no signiﬁcant differences in cortical volume, cortical
thickness, inner and outer diameter of the cortical bone, and MOI were observed
following the humanization or conventionalization of mice in comparison to the results
under the GF condition (Tables 3 and 4; Tables S1 and S2).
When comparing our results with published studies, there were some factors that
could account for the differences observed. First, the mode of transplantation of the
microbiota differed. Both studies conventionalized their mice with cecal contents.
However, as reported by Sjögren et al. (19), their conventionalization process was by
coprophagy, where cecal contents were put onto the fur of the mice, whereas we
conventionalized our animals by intragastric gavage after the cecal contents were
prepared and maintained under anaerobic conditions. While it is hard to speculate on
whether this ultimately culminated in pronounced differences in community coloniza-
tion, it cannot be excluded. Another possible reason for the observed differences is the
inherent differences between the microbiotas used to conventionalize mice manifest-
ing in different bone responses. It has been well documented that mice purchased from
different animal vendors and housed at different mouse facilities foster microbial
community colonization that is location speciﬁc (35). Our laboratory and others have
demonstrated that altering microbiome composition, through methods such as treat-
ing mice with pathogenic bacteria (36) or probiotics (20, 37, 38), can decrease or
increase bone density, respectively. Since there were no published community analysis
results reported by Sjögren et al. (19), it is impossible to compare their study with ours
with respect to the microbial communities used for the conventionalization study.
It is worth noting that recently published studies observed different impacts on
bone health following colonization of GF animals (20, 23). Speciﬁcally, one study
demonstrated that conventionalization of GF mice results in an increase in several
parameters of bone health (23). Under this condition, Schwarzer et al. (23) show that
the presence of the microbiota was associated with increases in bone volume per total
volume analyzed (BV/TV) and cortical thickness compared to those of the GF mice. In
TABLE 5 Histomorphometry of trabecular bone in distal femurs of conventionalized SW
mice
Parameter
Mean value  SEM for samples from
mice receiving indicated treatment
(no. of mice)
P valueGF (5) CONV-D (5)
OCL/bone surface (%) 12.91  4.01 16.41  5.51 0.25
MS/BS (%) 11.41  1.23 10.02  0.94 0.40
BFR (m/day) 0.19  0.03 0.11  0.01 0.21
MAR (m3/m2/day) 1.41  0.54 1.4  0.39 0.31
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contrast, another study, in female GF mice, did not ﬁnd that conventionalization
affected BV/TV measures, although signiﬁcant changes were observed in trabecular
architecture (20). These studies further support the notion that bone health is highly
regulated by the functional composition of the microbiota. The current compositional
analysis of the microbial analysis only provides information about what is present or
was once present. Even if the microbial compositions of two communities are different,
the functions of these communities may not differ. This is discussed further in a review
by Yan and Charles (39). To gain insight into functionalities being carried out by a
speciﬁc community, future studies focused on identifying speciﬁc microbial members
impacting bone health, as well as integrating metagenomics, transcriptomics, and
proteomics, may be necessary.
FIG 3 Conventionalization of GF SW mice resulted in no changes in bone marrow cell populations. Bone
marrow cells were ﬂushed from 8-week-old mice and stained for antibodies to quantify T cell populations
(CD3, CD4, and CD8) and osteoclast precursors (CD11b/GR1) by ﬂow cytometry. (a) Representative
images of ﬂow cytometry plots of cell percentages of total CD3 population for T cells and total bone
marrow population for osteoclast precursors. (b) Quantitation of the different cell populations. The results
for individual mice and mean values  SEM (n  3 to 10) are shown.
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Conclusions. The impact of intestinal microbes on bone metabolism has received
much attention in the last 5 years, with the initial publication in this area suggesting a
negative impact of gut bacteria on bone health. We have systematically tested several
different microbial communities in SW and C57BL/6 mice and have observed little
impact on bone metabolism. The results demonstrate that a negative effect of bacteria
on bone health cannot be generalized.
MATERIALS AND METHODS
GF mouse husbandry. The Institutional Animal Care and Use Committee (IACUC) at Baylor College
of Medicine approved all the protocols (protocol no. AN-6676) performed in this study. Germ-free (GF)
wild-type (WT) mice in the SW and C57BL/6 genetic background were generated by the Baylor College
of Medicine GF mouse facility. Germ-free mice were housed in ﬂexible-ﬁlm isolators (Class Biologically
Clean, Madison, WI) supplied with HEPA-ﬁltered air. The room’s light cycle was 12 h light/12 h dark. The
mice were given autoclaved food (5V5R; LabDiet, St. Louis, MO) and sterile tap water. Germ-free status
was veriﬁed through collection of composite mouse and isolator environmental samples, which were
subjected to aerobic, anaerobic, and fungal culture. Gram-stained smears of these samples were also
examined visually. Isolators were tested weekly during the initial validation and twice monthly once
established. The mice used in this study were conﬁrmed free of all bacteria, fungi, and metazoans by
these methods.
Viral infection status was veriﬁed by quarterly serology for excluded murine pathogens. Mice in the
facility are speciﬁc pathogen free (SPF) for the following excluded viruses: Sendai virus, pneumonia virus
of mice, mouse hepatitis virus, minute virus of mice, Theiler’s murine encephalomyelitis virus, reovirus,
lymphocytic choriomeningitis, ectromelia virus, K virus, polyomavirus, mouse adenovirus, rotavirus,
mouse cytomegalovirus, hantavirus, mouse parvovirus, and mouse norovirus.
The exclusion list for the SPF facility includes the following bacteria and metazoans, which we know
are not present in germ-free mice: Mycoplasma pulmonis, Helicobacter, Pseudomonas, Campylobacter,
Salmonella, Citrobacter, helminth intestinal parasites (pinworms) including Aspicularis tetraptera and
Syphacia obvelata, and ectoparasites (fur mites) including Radfordia afﬁnis, Myobia musculi, and Myocop-
tes musculinus.
Preparation of cecal and fecal samples and inoculation of the GF animals. Cecal contents were
collected from 4-week-old conventionally raised Swiss Webster (CONV-D) and C57BL/6 mice following
FIG 4 Osteoclast outgrowth from bone marrow cells of GF SW and conventionalized (CONV-D) mice. Bone
marrow cells were ﬂushed from the femurs of 8-week-old GF and CONV-D mice and stimulated for
differentiation with RANKL and M-CSF. TRAP cells were quantitated after 4 days of culture. (a) Represen-
tative images of bone marrow cells from mice treated under GF and CONV-D conditions. (b) Total osteoclast
(OC) numbers per well were quantitated. The results for individual mice and mean values SEM are shown.
Gut Colonization Does Not Cause Bone Loss in Germ-Free Mice
January/February 2018 Volume 3 Issue 1 e00545-17 msphere.asm.org 9
 o
n
 Septem
ber 10, 2019 at University of Aberdeen
http://m
sphere.asm
.org/
D
ow
nloaded from
 
euthanasia with 5% isoﬂurane until breathing cessation. Conﬁrmation of euthanasia was executed by
cervical dislocation and/or decapitation. Mouse cecal contents were expressed from the cecum into a
1.7-ml Eppendorf tube and immediately transferred into the anaerobic chamber. Human fecal samples
were collected and stored at 80°C as previously described (40). Surveying identiﬁed one as a
35-year-old vegetarian and the other as a 45-year-old omnivore. Samples from the omnivorous donor
came from two time points: at year 0 (sample C) and a year later (sample B). Prior to use, cecal and fecal
samples were resuspended in 25% (wt/vol) phosphate-buffered saline that was prereduced overnight in
an anaerobic chamber. Samples were vortexed for 5 min at 2,500 rpm on a plate shaker, followed by a
centrifugation step for 5 min at 200  g to facilitate the removal of the larger particles. For the
humanized mouse studies (Fig. 1), 100 &micro;l of the supernatant portion was administered by gavage
to each GF mouse in the SW background. All the remaining material was saved and stored in 20%
glycerol at80°C. For the conventionalized mouse studies (Fig. 2), the age, sex, and genetic background
of the donors were matched to their recipients (i.e., a GF female SW mouse was colonized with a fecal
sample from a WT female SW mouse).
Gavage and sample collection. At 4 weeks of age, GF mice were conventionalized with mouse cecal
contents or human fecal samples (as indicated in Results) by intragastric gavage. At various times
throughout the studies, fecal samples were collected as mice defecated and were stored at 80°C.
Calcein (10 mg/kg of body weight intraperitoneally) was injected 7 days and 2 days before euthanasia
to evaluate the dynamics of bone formation. Mice were euthanized with 5% isoﬂurane, continuing for
1 min following breathing cessation. Conﬁrmation of euthanasia was executed by cervical dislocation
and/or decapitation. Retro-orbital bleeding was performed for blood collection, and serum separation
was achieved by centrifugation at 4°C at 7,500 rpm for 10 min. Serum samples were stored at 80°C.
Intestinal sections were collected quickly after euthanasia and stored at 80°C. Cecal contents were
expressed from the cecum into a 1.7-ml Eppendorf tube for storage at 80°C. Femurs were ﬁxed in 10%
paraformaldehyde for 3 days and then stored in 70% ethanol at 4°C until micro-computed tomography
(CT) imaging. Following imaging, femurs were parafﬁn embedded for histomorphometry.
CT analysis of bone. CT was performed as described previously (41). Brieﬂy, femurs stored in 70%
ethanol were scanned using a Scanco CT-40 system (Scanco Medical AG, Brüttsellen, Switzerland)
located in the Micro-CT Core at Baylor College of Medicine. Scans were reconstructed at a 16-m
isotropic voxel size. Analysis of trabecular (cancellous) bone was performed by manually contouring a
region composed of 75 slices (1.2 mm) in the distal metaphyseal region of the femur. Parameters
including bone volume fraction (BVF; as deﬁned by bone volume per total volume analyzed [BV/TV]),
tissue mineral density (TMD), trabecular thickness (Tb. Th.), trabecular number (Tb. N.), and trabecular
spacing (Tb. Sp.) were measured using the Scanco software with a threshold value of 250. The length of
FIG 5 Analysis of mRNA expression in the colon and TNF- levels in serum. (a) The colonic mRNA
expression level of IL-17 was upregulated and that of IL-10 was downregulated due to conventional-
ization. (b) Serum levels of TNF- were unaffected following conventionalization. ELISA, enzyme-linked
immunosorbent assay. *, P  0.05 with respect to the results for SW GF mice, using Student’s t test.
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the femur was measured between the medial condyle and the top of the femoral head. Analysis of
cortical bone parameters was executed using an automated thresholding algorithm that is part of the
Scanco software package. The region of interest captured a distance spanning 50 slices (0.8 mm) from
the midshaft of the femur toward the distal femur and was measured with a threshold value of 220 using
the Scanco software package.
Static and dynamic histomorphometry. Fixed femurs (n  4 to 6 per group) were processed as
described previously (37, 38). Brieﬂy, ﬁxed femurs were parafﬁn embedded, sectioned, and analyzed by
microscopy. Calcein (100 l of 20 mg/ml dissolved in sterile saline) was supplemented by gavage at
7 days and 2 days prior to the end of the experiment. Its incorporation into growing bone allowed for
bone formation rate (BFR) and mineral apposition rate (MAR) measurements through quantitating the
amount of calcein along the bone surface. The distances between the calcein lines and length along the
bone surface were used to measure the MAR and BFR, respectively. A commercially available kit (catalog
number 387A; Sigma, St. Louis, MO) was used to quantitate tartrate-resistant alkaline phosphatase (TRAP)
activity, a measure of osteoclasts present, from sectioned trabecular bone.
FIG 6 Alpha and beta diversity measures for conventionalized SW and C57BL/6 mice indicate higher
diversity in SW mice and distinct clustering. (a) The comparison of OTUs in starting inocula and conven-
tionalized mice suggests a high level of colonization and efﬁcient microbiota transfer in both SW (male and
female) and C57BL/6 mouse genetic background. (b) In a PCoA plot, the results for the conventionalized
mice cluster together according to mouse genetic background and starting inocula.
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qRT-PCR. RNA extraction was performed with TRI Reagent (catalog number TR 118; Molecular Research
Center, Cincinnati, OH). Synthesis of cDNA was performed with SuperScript III reverse transcriptase (catalog
number 8080093; Thermo Fisher Scientiﬁc, Waltham, MA). A total of 1 g of RNA was reverse transcribed.
Brieﬂy, an Eppendorf Mastercycler EPS instrument was preheated to 65°C. A mixture containing RNA, 100 ng
of random hexamers (catalog number C1181; Promega, Madison, WI), and 1 l of 10 nM deoxynucleoside
triphosphates (dNTPs) (catalog number 18427088; Thermo Fisher Scientiﬁc, Waltham, MA) was placed into the
thermocycler for 5 min. Following 1 min on ice, a mixture containing the reverse transcriptase and RNaseOUT
was added to complete the cDNA synthesis. A cycle of 10 min at 25°C, 50 min at 50°C, and then 85°C for 5 min
was used. The cDNA was used immediately or stored at 20°C. The quantitative real-time PCR (qRT-PCR)
reaction mixtures contained 1 l of cDNA, 1 l each of forward and reverse primer (10 M), 7 l of
nuclease-free water, and 10 l of SYBR green PCR master mix (catalog number 170-8882; Bio-Rad, Hercules,
CA). A 2-step PCR ampliﬁcation protocol was used, with acquisition at the annealing and melting curve steps.
The protocol included an initial denaturation at 95°C for 30 s, followed by 40 cycles of denaturing at 95°C for
10 s and annealing at 51°C for 20 s. A melting curve was performed at the end at 95°C for 15 s and ramping
up from 60°C to 95°C at a rate of 0.2°C/s. Data analysis was performed according to the method described
by Pfafﬂ (42). The primer sequences used are as follows: HPRT forward, 5= GCTATAAATTCTTTGCTGACCTGC
T 3=; HPRT reverse, 5= AATTACTTTTATGTCCCCTGTTGACTG 3=; TNF- forward, 5= AGGCTGCCCCGACTACGT 3=;
TNF- reverse, 5= GACTTTCTCCTGGTATGAGATAGCAA 3=; IL-1 forward, 5= TCCCCGTCCCTATCGACAAAC 3=; IL-1
reverse, 5= GCGGTGATGTGGCATTTTCTG 3=; IL-6 forward, 5= ATCCAGTTGCCTTCTTGGGACTGA 3=; IL-6 reverse,
5= TAAGCCTCCGACTTGTGAAGTGGT 3=; 5-HTT forward, 5= ATTTCCGTTGGTGTTTCAGG 3=; 5-HTT reverse,
5= CGTCTGTCATCTGCATCCCT 3=; IFN- forward, 5= GGCTGTCCCTGAAAGAAAGC 3=; IFN- reverse, 5= GAGCG
AGTTATTTGTCATTCGG 3=; IL-17 forward, 5= TGAGCTTCCCAGATCACAGA 3=; IL-17 reverse, 5= TCCAGAAGGCC
CTCAGACTA 3=; IL-10 forward, 5= GGTTGCCAAGCCTTATCGGA 3=; and IL-10 reverse, 5= ACCTGCTCCACTGCCT
TGCT 3=.
Flow cytometry. Bone marrow cells were ﬂushed and collected from femurs (n 8 to 10 per group).
An amount of 1  106 cells was plated per well in a 96-well plate. The staining was performed as
described by Collins et al. (43). Brieﬂy, cells were blocked with Fc block (Becton Dickinson Pharmingen,
Franklin Lakes, NJ) for 15 min and then stained with antibodies to CD3 (catalog number 56-0032;
eBioscience, San Diego, CA), CD4 (catalog number 11-0041; eBioscience, San Diego, CA), CD8a (catalog
number 35-0081; eBioscience, San Diego, CA), GR1/Lys-6G (catalog number 53-5931; eBioscience, San
Diego, CA), and CD11b (catalog number 12-0113; eBioscience, San Diego, CA) for 30 min. Then, cells were
ﬁxed and data were acquired using the Becton Dickinson LSRII ﬂow cytometer. Data analysis was
performed using the FlowJo software package (FlowJo, LLC).
Osteoclast outgrowth assay. Primary bone marrow cells were isolated from femurs, and amounts
of 4.5 105 cells per well were plated in a 48-well plate (catalog number CLS3548; Corning, Corning, NY)
format. The plated cells were maintained in minimum essential medium alpha (MEM) (catalog number
12561; Invitrogen, San Diego, CA) plus 10% fetal bovine serum (FBS) (catalog number 16000044; Thermo
Fisher Scientiﬁc, Waltham, MA) containing 1% penicillin-streptomycin (catalog number 15140122; Invit-
rogen, San Diego, CA). To induce osteoclast differentiation, cells were stimulated with 30 ng/ml of RANKL
(catalog number Q3TWY5; R&D Systems, Minneapolis, MN) and 2 ng/ml of M-CSF (catalog number
Q3U4F9; R&D Systems, Minneapolis, MN). The complete growth medium was replenished every 2 days.
After 4 days, the cells were ﬁxed and stained for tartrate-resistant acid phosphatase (TRAP) according to
the manufacturer’s protocol (catalog number 387A; Sigma-Aldrich, St. Louis, MO). Cells staining for TRAP
and multinucleated (3) were considered osteoclasts.
DNA extraction from mouse fecal samples, 16S rRNA gene ampliﬁcation, and sequencing. For
16S rRNA gene sequencing, DNA was extracted by bead beating followed by the use of the Qiagen
DNEasy tissue kit as described previously (37). PCR ampliﬁcation of the V4 region of the 16S rRNA gene
was performed with Phusion high-ﬁdelity DNA polymerase (catalog number M0530; New England
Biolabs, Ipswich, MA) using previously described primers and a previously described protocol (40, 44).
PCRs were performed in duplicate. Each reaction mixture was composed of 4 l of template, 1 Phusion
high-ﬁdelity buffer, 200 M dNTPs (catalog number M0530; New England Biolabs, Ipswich, MA), 10 nM
forward and reverse primers, 0.2 units of Phusion DNA polymerase, and PCR-grade water to adjust the
ﬁnal volume to 20 l. A 3-step PCR ampliﬁcation cycle was used and included an initial denaturation at
98°C for 30 s, followed by 30 cycles of denaturing at 98°C for 10 s, annealing at 51°C for 20 s, and
extension at 72°C for 1 min. Replicates were pooled and cleaned using the Agencourt AMPure XP kit
(catalog number A63880; Beckman Coulter, Inc., Indianapolis, IN). DNA sample concentrations were
measured using the Quant-iT kit (catalog number Q33120; Thermo Fisher Scientiﬁc, Waltham, MA) and
pooled at equimolar ratios. Sequencing was performed on an Illumina MiSeq platform (Illumina, Inc., San
Diego, CA).
Microbial community analysis. The MiSeq pipeline in mothur was used to process sequence data
(45). The MiSeq pipeline for mothur (essentially as described previously [46] and the MiSEQ standard
operating procedure [SOP] version 28 March 2013 [http://www.mothur.org/wiki/MiSeq_SOP]) were used
to process sequence data. Following alignment of forward and reverse reads, sequences were quality
trimmed and aligned to the Silva 16S rRNA gene reference database formatted for mothur. Sequences
were then trimmed to overlap the same region of the 16S rRNA gene and preclustered to clusters with
99% identity, and potentially chimeric sequences were identiﬁed and removed using the mothur
implementation of UCHIME. Sequences were classiﬁed according to the mothur-formatted ribosomal
database project version 9 (August 2013) using the Bayesian classiﬁer in mothur, and those sequences
classiﬁed as Eukarya, Archaea, chloroplast, mitochondria, or unknown were removed. The sequence data
were then ﬁltered to remove any sequences present only once in the data set. After building a distance
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matrix from the remaining sequences with the default parameters in mothur, sequences were clustered
into operational taxonomic units (OTUs) with 97% similarity using the average-neighbor algorithm in
mothur. The taxonomic assignments for each OTU are the majority consensus taxonomic assignment for
each sequence within the OTU. Prior to analysis with the phyloseq package of R, additional ﬁltering of
the OTU table was done to remove rare OTUs. Namely, those OTUs present in less than 3 samples and/or
that contained less than 25 sequences were removed. These ﬁltering steps reduced the number of OTUs
from 6,306 to 923 but only decreased the number of sequences per sample by a mean and standard error
of the mean (SEM) of 0.7%  0.4% (range, 0.1 to 2.3%). The data set included 4,373,773 high-quality
sequences. Following the removal of singletons and clustering based off of 97% similarity, 471 OTUs were
identiﬁed across all samples (n  52), with an average rarefaction depth of 14,920 reads per sample. The
cutoff value for inclusion in downstream analyses was representing at least 0.01% abundance for that
particular community. Analysis and visualization of microbiome communities were conducted in R,
utilizing the phyloseq package to import sample data and calculate alpha and beta diversity metrics (47).
Statistical analyses. The results are presented as mean values standard errors of the means (SEM).
An unpaired t test was used to assess differences between groups. The cutoff for signiﬁcance was a P
value of0.05. One-way analysis of variance (ANOVA) was applied when more than 2 groups were being
compared. For example, a one-way ANOVA was applied between subjects to compare the effect of
different microbiotas on bone volume fraction. For microbial community analysis, the levels of signiﬁ-
cance of categorical variables were determined using the nonparametric Mann-Whitney test for two-
category comparisons or the Kruskal-Wallis test for three or more categories. Principal-coordinate
analysis (PCoA) plots employed the Monte Carlo permutation test to estimate P values (48). All P values
were adjusted for multiple comparisons by taking into account the false discovery rate (49).
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